Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Risk of Progression in MS depends on the Features of Preceding Relapses: Application to First Generation Immunomodulating Theraphy
Multiple Sclerosis
(-)
185
Authors/Disclosures
Helen Tedeholm
PRESENTER
No disclosure on file
Bengt Skoog (Sahlgenska sjukhuset Gbg) No disclosure on file
Bjorn Runmarker, MD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file